MBX Biosciences, Inc. (MBX)
53.31
-1.23
(-2.26%)
USD |
NASDAQ |
Oct 08, 16:00
53.31
0.00 (0.00%)
After-Hours: 20:00
MBX Biosciences Price to Book Value : 6.242 for Oct. 8, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 6.386 |
| October 06, 2026 | 6.664 |
| October 05, 2026 | 6.854 |
| October 02, 2026 | 6.850 |
| October 01, 2026 | 6.621 |
| September 30, 2026 | 6.863 |
| September 29, 2026 | 6.762 |
| September 28, 2026 | 6.737 |
| September 25, 2026 | 6.279 |
| September 24, 2026 | 6.485 |
| September 23, 2026 | 6.778 |
| September 22, 2026 | 7.257 |
| September 21, 2026 | 7.135 |
| September 18, 2026 | 7.366 |
| September 17, 2026 | 7.480 |
| September 16, 2026 | 7.209 |
| September 15, 2026 | 7.151 |
| September 14, 2026 | 6.965 |
| September 11, 2026 | 6.910 |
| September 10, 2026 | 7.135 |
| September 09, 2026 | 7.366 |
| September 08, 2026 | 7.375 |
| September 04, 2026 | 7.226 |
| September 03, 2026 | 7.191 |
| September 02, 2026 | 7.129 |
| Date | Value |
|---|---|
| September 01, 2026 | 7.134 |
| August 31, 2026 | 7.212 |
| August 28, 2026 | 7.376 |
| August 27, 2026 | 7.773 |
| August 26, 2026 | 7.816 |
| August 25, 2026 | 8.034 |
| August 24, 2026 | 7.773 |
| August 21, 2026 | 7.766 |
| August 20, 2026 | 7.768 |
| August 19, 2026 | 8.008 |
| August 18, 2026 | 7.788 |
| August 17, 2026 | 7.991 |
| August 14, 2026 | 8.028 |
| August 13, 2026 | 7.854 |
| August 12, 2026 | 7.841 |
| August 11, 2026 | 7.729 |
| August 10, 2026 | 7.745 |
| August 07, 2026 | 7.940 |
| August 06, 2026 | 7.857 |
| August 05, 2026 | 7.901 |
| August 04, 2026 | 8.278 |
| August 03, 2026 | 7.541 |
| July 31, 2026 | 7.719 |
| July 30, 2026 | 7.781 |
| July 29, 2026 | 7.489 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Amylyx Pharmaceuticals, Inc. | 12.66 |
| ANI Pharmaceuticals, Inc. | 2.768 |
| Corcept Therapeutics, Inc. | 18.13 |
| Veru, Inc. | 1.448 |
| Johnson & Johnson | 7.268 |
Price to Book Value Related Metrics
| PEG Ratio | -5.041 |
| Price | 53.31 |
| Earnings Yield | -4.51% |
| Market Cap | 2.556B |
| PEGY Ratio | -5.041 |